Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Stable Plaque Psoriasis”

6 trials

Showing 6 of 6 results

Testing effectiveness (Phase 2)Study completedNCT02949388
What this trial is testing

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
Innovation Pharmaceuticals, Inc. 199
Post-approval studies (Phase 4)Study completedNCT01012713
What this trial is testing

Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
University of California, San Francisco 30
Large-scale testing (Phase 3)Study completedNCT01891864
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

Who this might be right for
Chronic Stable Plaque Psoriasis
Sandoz 531
Testing effectiveness (Phase 2)Ended earlyNCT02243787
What this trial is testing

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Covagen 24
Large-scale testing (Phase 3)Study completedNCT02445807
What this trial is testing

The Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
Promius Pharma, LLC 265
Testing effectiveness (Phase 2)Study completedNCT01634087
What this trial is testing

Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Incyte Corporation 50

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation